Entheon Biomedical (ENTBF)
OTHER OTC:ENTBF
Holding ENTBF?
Track your performance easily

Entheon Biomedical (ENTBF) Technical Analysis

33 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
4Neutral
12Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
10Bearish
Entheon Biomedical’s (ENTBF) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Entheon Biomedical is a Buy.
Entheon Biomedical’s (ENTBF) 20-Day exponential moving average is 0.09, while Entheon Biomedical’s (ENTBF) share price is <$0.1, making it a Sell.
Entheon Biomedical’s (ENTBF) 50-Day exponential moving average is 0.09, while Entheon Biomedical’s (ENTBF) share price is <$0.1, making it a Sell.

Entheon Biomedical (ENTBF) Pivot Points

Sep 20, 2024, 04:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.01
0.04
0.07
0.10
0.13
0.16
0.19
Fibonacci
0.04
0.06
0.08
0.10
0.12
0.14
0.16
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Entheon Biomedical (ENTBF) Moving Averages

Sep 20, 2024, 04:26 PM
Period
Simple
Exponential
MA5
0.09Sell
0.09Sell
MA10
0.10Sell
0.09Sell
MA20
0.09Sell
0.09Sell
MA50
0.08Sell
0.09Sell
MA100
0.10Sell
0.09Sell
Entheon Biomedical’s (ENTBF) 10-Day exponential moving average is 0.09, while Entheon Biomedical’s (ENTBF) share price is <$0.1, making it a Sell.
Entheon Biomedical’s (ENTBF) 100-Day exponential moving average is 0.09, while Entheon Biomedical’s (ENTBF) share price is <$0.1, making it a Sell.
Entheon Biomedical’s (ENTBF) stock price is <$0.1 and Entheon Biomedical’s (ENTBF) 50-day simple moving average is 0.08, creating a Sell signal.
Entheon Biomedical’s (ENTBF) stock price is <$0.1 and Entheon Biomedical’s (ENTBF) 100-day simple moving average is 0.10, creating a Sell signal.

Entheon Biomedical (ENTBF) Technical Indicators

Sep 20, 2024, 04:26 PM
Name
Value
Implied Action
RSI (14)
37.35
Neutral
STOCH (9,6)
44.68
Neutral
STOCHRSI (14)
42.44
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
10.06
Buy
Williams %R
-93.24
Buy
CCI (14)
-225.38
Buy
ATR (14)
0.02
-
Ultimate Oscillator
37.87
Neutral
ROC
-25.00
Sell
Entheon Biomedical’s (ENTBF) Relative Strength Index (RSI) is 37.35, creating a Neutral signal.
Entheon Biomedical’s (ENTBF) Trend Strength Indicator (ADX) is 10.06, creating a Buy signal.
Entheon Biomedical’s (ENTBF) Commodity Channel Index (CCI) is -225.38, creating a Buy signal.
Entheon Biomedical’s (ENTBF) Price Rate of Change (ROC) is -25.00, creating a Sell signal.

FAQ

Is ENTBF a Buy, Hold, or Sell?
Based on ENTBF’s technical indicators, ENTBF is a Sell.
    What is ENTBF’s RSI (14)?
    ENTBF’s RSI (14) is 37.35, which suggests ENTBF is a Neutral.
      What is ENTBF’s MACD?
      ENTBF’s MACD is <0.01, which suggests ENTBF is a Buy.
        What is ENTBF’s 5-day moving average?
        ENTBF’s 5-day moving average is 0.09, which suggests ENTBF is a Sell.
          What is ENTBF’s 20-day moving average?
          ENTBF 20-day moving average is 0.09, which suggests ENTBF is a Sell.
            What is ENTBF’s 50-day moving average?
            ENTBF’s 50-day moving average is 0.08, which suggests ENTBF is a Sell.
              What is ENTBF’s 200-day moving average?
              Currently, no data Available
              What is ENTBF’s Williams % R (14)?
              ENTBF’s Williams % R (14) is -93.24, which suggests ENTBF is a Buy.
                What is ENTBF’s CCI (14)?
                ENTBF’s CCI (14) is -225.38, which suggests ENTBF is a Buy.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis